These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22950971)

  • 21. Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs.
    Wildner O; Hoffmann D; Jogler C; Uberla K
    Cancer Gene Ther; 2003 Oct; 10(10):791-802. PubMed ID: 14502232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central nervous system toxicity of two adenoviral vectors encoding variants of the herpes simplex virus type 1 thymidine kinase: reduced cytotoxicity of a truncated HSV1-TK.
    Cowsill C; Southgate TD; Morrissey G; Dewey RA; Morelli AE; Maleniak TC; Forrest Z; Klatzmann D; Wilkinson GW; Löwenstein PR; Castro MG
    Gene Ther; 2000 Apr; 7(8):679-85. PubMed ID: 10800091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma.
    Chiocca EA; Aguilar LK; Bell SD; Kaur B; Hardcastle J; Cavaliere R; McGregor J; Lo S; Ray-Chaudhuri A; Chakravarti A; Grecula J; Newton H; Harris KS; Grossman RG; Trask TW; Baskin DS; Monterroso C; Manzanera AG; Aguilar-Cordova E; New PZ
    J Clin Oncol; 2011 Sep; 29(27):3611-9. PubMed ID: 21844505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of high-capacity helper-dependent adenoviral vector genomes in vitro and in vivo, using quantitative TaqMan real-time polymerase chain reaction.
    Puntel M; Curtin JF; Zirger JM; Muhammad AK; Xiong W; Liu C; Hu J; Kroeger KM; Czer P; Sciascia S; Mondkar S; Lowenstein PR; Castro MG
    Hum Gene Ther; 2006 May; 17(5):531-44. PubMed ID: 16716110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single dose GLP toxicity and biodistribution study of a conditionally replicative adenovirus vector, CRAd-S-pk7, administered by intracerebral injection to Syrian hamsters.
    Kim JW; Auffinger B; Spencer DA; Miska J; Chang AL; Kane JR; Young JS; Kanojia D; Qiao J; Mann JF; Zhang L; Wu M; Ahmed AU; Aboody KS; Strong TV; Hébert CD; Lesniak MS
    J Transl Med; 2016 May; 14(1):134. PubMed ID: 27184224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between adenoviral and retroviral vectors for the transduction of the thymidine kinase PET reporter gene in rat mesenchymal stem cells.
    Roelants V; Labar D; de Meester C; Havaux X; Tabilio A; Gambhir SS; Di Ianni M; Bol A; Bertrand L; Vanoverschelde JL
    J Nucl Med; 2008 Nov; 49(11):1836-44. PubMed ID: 18984872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory thoughts about glioma gene therapy.
    Kielian T; Hickey WF
    Nat Med; 1999 Nov; 5(11):1237-8. PubMed ID: 10545984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gene therapy for cerebral tumors: use of an adenovirus in the glioma C6 rat model].
    Maron A
    Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):377-80. PubMed ID: 10992887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transduction efficiency of adenoviral vectors into human glioma cells increased by association with cationic liposomes.
    Ryuke Y; Mizuno M; Natsume A; Yoshida J
    Neurol Med Chir (Tokyo); 2000 May; 40(5):256-60. PubMed ID: 11980090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of relapsed malignant glioma with an adenoviral vector containing the herpes simplex thymidine kinase gene followed by ganciclovir.
    Smitt PS; Driesse M; Wolbers J; Kros M; Avezaat C
    Mol Ther; 2003 Jun; 7(6):851-8. PubMed ID: 12788659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Towards global and long-term neurological gene therapy: unexpected transgene dependent, high-level, and widespread distribution of HSV-1 thymidine kinase throughout the CNS.
    Zermansky AJ; Bolognani F; Stone D; Cowsill CM; Morrissey G; Castro MG; Löwenstein PR
    Mol Ther; 2001 Nov; 4(5):490-8. PubMed ID: 11708886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Long and Winding Road: From the High-Affinity Choline Uptake Site to Clinical Trials for Malignant Brain Tumors.
    Lowenstein PR; Castro MG
    Adv Pharmacol; 2016; 76():147-73. PubMed ID: 27288077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flt3L and TK gene therapy eradicate multifocal glioma in a syngeneic glioblastoma model.
    King GD; Muhammad AK; Curtin JF; Barcia C; Puntel M; Liu C; Honig SB; Candolfi M; Mondkar S; Lowenstein PR; Castro MG
    Neuro Oncol; 2008 Feb; 10(1):19-31. PubMed ID: 18079358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
    Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marmosets as a preclinical model for testing "off-label" use of doxycycline to turn on Flt3L expression from high-capacity adenovirus vectors.
    VanderVeen N; Paran C; Appelhans A; Krasinkiewicz J; Lemons R; Appelman H; Doherty R; Palmer D; Ng P; Lowenstein PR; Castro MG
    Mol Ther Methods Clin Dev; 2014 Feb; 1():10-. PubMed ID: 25068145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy.
    Lanuti M; Gao GP; Force SD; Chang MY; El Kouri C; Amin KM; Hughes JV; Wilson JM; Kaiser LR; Albelda SM
    Hum Gene Ther; 1999 Feb; 10(3):463-75. PubMed ID: 10048398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical studies for pharmacokinetics and biodistribution of Ad-stTRAIL, an adenovirus delivering secretable trimeric TRAIL for gene therapy.
    Kim CY; Park SH; Jeong M; Kwon OS; Doh H; Kang SH; Robbins PD; Kim BM; Seol DW; Kim BG
    Exp Mol Med; 2011 Oct; 43(10):580-6. PubMed ID: 21822049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human Flt3L generates dendritic cells from canine peripheral blood precursors: implications for a dog glioma clinical trial.
    Xiong W; Candolfi M; Liu C; Muhammad AK; Yagiz K; Puntel M; Moore PF; Avalos J; Young JD; Khan D; Donelson R; Pluhar GE; Ohlfest JR; Wawrowsky K; Lowenstein PR; Castro MG
    PLoS One; 2010 Jun; 5(6):e11074. PubMed ID: 20552015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.